<?xml version="1.0" encoding="UTF-8"?>
<p id="p0399" num="0399" sourceFile="EP 1326865B1.xml">The title compound was prepared using the procedure described in Example 93 replacing 2-pyridin-3-ylethanamine with 2-morpholin-4-yl-2-pyridin-3-ylethylamine.
  <br/>
  <sup>1</sup>H NMR (DMSO, 400MHz) δ 12.40 (1H, s), 9.14 (1H, m), 9.05 (1H, d, 
  <i>J</i>=4.0 Hz), 8.68 (1H, s), 8.60-8.50 (2H, m), 8.00 (1H, m), 7.72 (1H, dd, 
  <i>J</i>=4.2 and 8.4Hz), 7.55-7.40 (4H, m), 4.63 (1H, dd, 
  <i>J</i>=15.4 and 6.8 Hz), 4.53 (1H, dd, 
  <i>J</i>=15.4 and 5.7 Hz), 4.00-3.00 (8H, m) ppm.
  <br/> FAB MS calcd for C
  <sub>27</sub>H
  <sub>26</sub>Cl
  <sub>2</sub>N
  <sub>6</sub>O
  <sub>3</sub> 553 (MH
  <sup>+</sup>), found 553.
  <br/> FAB HRMS exact mass calc'd for C
  <sub>27</sub>H
  <sub>26</sub>Cl
  <sub>2</sub>N
  <sub>6</sub>O
  <sub>3</sub> 553.1516 (MH
  <sup>+</sup>), found 553.1545.
</p>
